Matarin Capital Management’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
$3.18M Sell
41,208
-21,065
-34% -$1.62M 0.78% 46
2020
Q3
$4.59M Sell
62,273
-8,520
-12% -$627K 0.96% 22
2020
Q2
$5.2M Sell
70,793
-56,271
-44% -$4.13M 1.04% 14
2020
Q1
$7.34M Sell
127,064
-7,208
-5% -$416K 1.14% 8
2019
Q4
$10.5M Sell
134,272
-57,218
-30% -$4.49M 1.01% 15
2019
Q3
$13.1M Buy
191,490
+39,718
+26% +$2.72M 0.99% 19
2019
Q2
$12.1M Buy
151,772
+12,804
+9% +$1.02M 0.86% 37
2019
Q1
$11.7M Sell
138,968
-3,743
-3% -$314K 0.85% 36
2018
Q4
$16.8M Sell
142,711
-7,922
-5% -$933K 1.36% 3
2018
Q3
$18.2M Buy
150,633
+11,191
+8% +$1.35M 1.17% 11
2018
Q2
$16.1M Sell
139,442
-17,442
-11% -$2.01M 1.16% 9
2018
Q1
$13.5M Buy
156,884
+5,112
+3% +$439K 1.01% 19
2017
Q4
$11.2M Sell
151,772
-14,642
-9% -$1.08M 0.88% 32
2017
Q3
$9.6M Buy
166,414
+33,613
+25% +$1.94M 0.82% 38
2017
Q2
$8.51M Sell
132,801
-4,628
-3% -$297K 0.79% 37
2017
Q1
$7.92M Sell
137,429
-9,163
-6% -$528K 0.78% 37
2016
Q4
$8.97M Buy
146,592
+1,082
+0.7% +$66.2K 1.01% 14
2016
Q3
$10.1M Buy
145,510
+6,442
+5% +$446K 1.11% 8
2016
Q2
$7.75M Sell
139,068
-1,352
-1% -$75.3K 1.05% 11
2016
Q1
$8.52M Buy
140,420
+9,274
+7% +$563K 1.19% 5
2015
Q4
$8.38M Buy
131,146
+15,896
+14% +$1.02M 1.25% 5
2015
Q3
$7.72M Buy
115,250
+41,632
+57% +$2.79M 1.58% 6
2015
Q2
$5.03M Buy
73,618
+4,684
+7% +$320K 1.44% 3
2015
Q1
$3.83M Buy
68,934
+12,290
+22% +$683K 1.16% 8
2014
Q4
$2.91M Buy
56,644
+1,040
+2% +$53.3K 1.27% 10
2014
Q3
$2.05M Buy
55,604
+894
+2% +$32.9K 0.94% 24
2014
Q2
$2.14M Buy
54,710
+10,198
+23% +$398K 0.95% 23
2014
Q1
$1.68M Buy
44,512
+7,980
+22% +$301K 0.99% 30
2013
Q4
$1.38M Buy
36,532
+12,086
+49% +$457K 0.85% 61
2013
Q3
$1.06M Buy
+24,446
New +$1.06M 0.89% 46